|
|
 |
|
| Generic Name |
Category |
Stage (U.S.A.) |
Remarks |
| KW-6002 |
Parkinson's disease |
Phase III |
Adenosine A2a Antagonist |
| KW-2401 (UCN-01) |
Anticancer |
Phase II |
Sponsored by National Cancer Institute |
| KW-7158 |
Urinary incontinence |
Phase IIa |
|
| KW-2871 |
Anticancer |
Phase I/IIa |
Chimeric monoclonal antibody |
|
|
